224 related articles for article (PubMed ID: 29295868)
1. The immunoproteasome-specific inhibitor ONX 0914 reverses susceptibility to acute viral myocarditis.
Althof N; Goetzke CC; Kespohl M; Voss K; Heuser A; Pinkert S; Kaya Z; Klingel K; Beling A
EMBO Mol Med; 2018 Feb; 10(2):200-218. PubMed ID: 29295868
[TBL] [Abstract][Full Text] [Related]
2. Mitigated viral myocarditis in A/J mice by the immunoproteasome inhibitor ONX 0914 depends on inhibition of systemic inflammatory responses in CoxsackievirusB3 infection.
Goetzke CC; Althof N; Neumaier HL; Heuser A; Kaya Z; Kespohl M; Klingel K; Beling A
Basic Res Cardiol; 2021 Feb; 116(1):7. PubMed ID: 33523326
[TBL] [Abstract][Full Text] [Related]
3. ONX 0914 Lacks Selectivity for the Cardiac Immunoproteasome in CoxsackievirusB3 Myocarditis of NMRI Mice and Promotes Virus-Mediated Tissue Damage.
Neumaier HL; Harel S; Klingel K; Kaya Z; Heuser A; Kespohl M; Beling A
Cells; 2020 Apr; 9(5):. PubMed ID: 32354159
[No Abstract] [Full Text] [Related]
4. Silencing the CSF-1 Axis Using Nanoparticle Encapsulated siRNA Mitigates Viral and Autoimmune Myocarditis.
Meyer IS; Goetzke CC; Kespohl M; Sauter M; Heuser A; Eckstein V; Vornlocher HP; Anderson DG; Haas J; Meder B; Katus HA; Klingel K; Beling A; Leuschner F
Front Immunol; 2018; 9():2303. PubMed ID: 30349538
[TBL] [Abstract][Full Text] [Related]
5. Heart-Specific Immune Responses in an Animal Model of Autoimmune-Related Myocarditis Mitigated by an Immunoproteasome Inhibitor and Genetic Ablation.
Bockstahler M; Fischer A; Goetzke CC; Neumaier HL; Sauter M; Kespohl M; Müller AM; Meckes C; Salbach C; Schenk M; Heuser A; Landmesser U; Weiner J; Meder B; Lehmann L; Kratzer A; Klingel K; Katus HA; Kaya Z; Beling A
Circulation; 2020 Jun; 141(23):1885-1902. PubMed ID: 32160764
[TBL] [Abstract][Full Text] [Related]
6. Effect of interleukin-15 on the course of myocarditis in Coxsackievirus B3-infected BALB/c mice.
Bigalke B; Schwimmbeck PL; Haas CS; Lindemann S
Can J Cardiol; 2009 Jul; 25(7):e248-54. PubMed ID: 19584981
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis.
Basler M; Mundt S; Muchamuel T; Moll C; Jiang J; Groettrup M; Kirk CJ
EMBO Mol Med; 2014 Feb; 6(2):226-38. PubMed ID: 24399752
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.
Jenke A; Holzhauser L; Löbel M; Savvatis K; Wilk S; Weithäuser A; Pinkert S; Tschöpe C; Klingel K; Poller W; Scheibenbogen C; Schultheiss HP; Skurk C
Basic Res Cardiol; 2014 May; 109(3):408. PubMed ID: 24691762
[TBL] [Abstract][Full Text] [Related]
9. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
[TBL] [Abstract][Full Text] [Related]
10. Innate immune interleukin-1 receptor-associated kinase 4 exacerbates viral myocarditis by reducing CCR5(+) CD11b(+) monocyte migration and impairing interferon production.
Valaperti A; Nishii M; Liu Y; Naito K; Chan M; Zhang L; Skurk C; Schultheiss HP; Wells GA; Eriksson U; Liu PP
Circulation; 2013 Oct; 128(14):1542-54. PubMed ID: 24030499
[TBL] [Abstract][Full Text] [Related]
11. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis.
Henke A; Huber S; Stelzner A; Whitton JL
J Virol; 1995 Nov; 69(11):6720-8. PubMed ID: 7474082
[TBL] [Abstract][Full Text] [Related]
12. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis.
Schmidtke M; Glück B; Merkle I; Hofmann P; Stelzner A; Gemsa D
J Med Virol; 2000 Aug; 61(4):518-26. PubMed ID: 10897072
[TBL] [Abstract][Full Text] [Related]
13. The immunoproteasome controls the availability of the cardioprotective pattern recognition molecule Pentraxin3.
Paeschke A; Possehl A; Klingel K; Voss M; Voss K; Kespohl M; Sauter M; Overkleeft HS; Althof N; Garlanda C; Voigt A
Eur J Immunol; 2016 Mar; 46(3):619-33. PubMed ID: 26578407
[TBL] [Abstract][Full Text] [Related]
14. Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomes.
Szalay G; Meiners S; Voigt A; Lauber J; Spieth C; Speer N; Sauter M; Kuckelkorn U; Zell A; Klingel K; Stangl K; Kandolf R
Am J Pathol; 2006 May; 168(5):1542-52. PubMed ID: 16651621
[TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice.
Gao G; Zhang J; Si X; Wong J; Cheung C; McManus B; Luo H
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H401-8. PubMed ID: 18515649
[TBL] [Abstract][Full Text] [Related]
16. Natural Products as a Paradigm for the Treatment of Coxsackievirus - induced Myocarditis.
Khanna M; Gautam A; Rajput R; Sharma L
Curr Top Med Chem; 2020; 20(8):607-616. PubMed ID: 31995007
[TBL] [Abstract][Full Text] [Related]
17. Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.
Stein EA; Pinkert S; Becher PM; Geisler A; Zeichhardt H; Klopfleisch R; Poller W; Tschöpe C; Lassner D; Fechner H; Kurreck J
J Infect Dis; 2015 Feb; 211(4):613-22. PubMed ID: 25193982
[TBL] [Abstract][Full Text] [Related]
18. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
[TBL] [Abstract][Full Text] [Related]
19. Differential interferon responses enhance viral epitope generation by myocardial immunoproteasomes in murine enterovirus myocarditis.
Jäkel S; Kuckelkorn U; Szalay G; Plötz M; Textoris-Taube K; Opitz E; Klingel K; Stevanovic S; Kandolf R; Kotsch K; Stangl K; Kloetzel PM; Voigt A
Am J Pathol; 2009 Aug; 175(2):510-8. PubMed ID: 19590042
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide and murine coxsackievirus B3 myocarditis: aggravation of myocarditis by inhibition of nitric oxide synthase.
Hiraoka Y; Kishimoto C; Takada H; Nakamura M; Kurokawa M; Ochiai H; Shiraki K
J Am Coll Cardiol; 1996 Nov; 28(6):1610-5. PubMed ID: 8917278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
